Pealkiri: 

Prevalence of HIV and other infections and risk behavior among injecting drug users in Latvia, Lithuania and Estonia in 2007

Väljaandja/tellija: Tervise Arengu Instituut, Tartu Ülikool
Märksõnad: sõltuvushäired, narkomaania, narkootikumid, Läti, Leedu, nakkushaigused, süstlavahetusteenus, kahjude vähendamine, asendusravi, võõrutusravi, terviseteenused, HIV, tuberkuloos, AIDS, sotsiaalmajanduslikud näitajad, demograafilised näitajad, riskikäitumine, ennetamine, vangid, vanglad, seksuaalkäitumine, prostitutsioon, ennetamine, nakatumine, B-hepatiit, C-hepatiit, süüfilis
Välja antud: 2009
Tüüp: Uuring/analüüs
Failid:
Nimi SuurusFormaat
TerviseArenguInstituut2009.pdf903.79 kBAdobe PDF
TerviseArenguInstituut2009_venek.pdf974.22 kBAdobe PDF
Alamvaldkonnad:Sõltuvusainete tarvitamine
Nakkushaigused
Riskikäitumine
Terviseteenuste korraldus, kättesaadavus ja kvaliteet
Kirjeldus: The current report provides results from a cross-sectional bio-behavioural study on HIV and related infections and risk behaviours among current IDUs in the capital cities of the three Baltic countries. The first section of the report provides basic information on the three Baltic countries in general, and injecting drug use, HIV and other infections' epidemiological situations, health care and harm reduction services in more detail. The second section focuses on the methodology and results of the study and the third provides a short discussion and guidance for future action to tackle the HIV epidemic and its consequences among IDUs in Baltic countries.

The main aim of the study was to evaluate the prevalence of HIV, HBV, HCV, syphilis markers and tuberculosis infection and related risk behaviours among injecting drug users in Riga (Latvia), Vilnius (Lithuania), and Tallinn (Estonia).
Specific objectives
1) To assess the prevalence of HIV, HBV, HCV infections and syphilis markers among IDUs.
2) To identify risk factors related to HIV infection (sexual behaviour, knowledge on HIV transmission, drug use patterns, socioeconomic status, etc).
3) To collect data from IDUs about their contacts with harm-reduction programs, drug-addiction and other health-care services, and imprisonment.
4) To assess the prevalence of M. tuberculosis (MTB) infection markers among IDUs.